{{Rsnum
|rsid=11244841
|Gene=ADAM12
|Chromosome=10
|position=127834566
|Orientation=plus
|GMAF=0.191
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.8 | 35.4 | 55.8
| HCB | 4.4 | 27.9 | 67.6
| JPT | 1.8 | 32.7 | 65.5
| YRI | 0.0 | 11.6 | 88.4
| ASW | 0.0 | 7.0 | 93.0
| CHB | 4.4 | 27.9 | 67.6
| CHD | 1.8 | 31.2 | 67.0
| GIH | 2.0 | 19.8 | 78.2
| LWK | 0.9 | 7.3 | 91.8
| MEX | 7.0 | 38.6 | 54.4
| MKK | 0.0 | 12.8 | 87.2
| TSI | 6.9 | 40.2 | 52.9
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs11244841
|Name_s=
|Gene_s=ADAM12
|Feature=
|Evidence=PubMed ID:17553421; PubMed ID:19118814
|Annotation=This variant is nominally associated with late-onset Alzheimer disease (LOAD) in 2 GWAS studies.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363845
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11244841
|overall_frequency_n=20
|overall_frequency_d=128
|overall_frequency=0.15625
|n_genomes=14
|n_genomes_annotated=0
|n_haplomes=18
|n_articles=0
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}